Given Imaging Pill Easy For Investors To Swallow In April: Stock Up 27%
This article was originally published in The Gray Sheet
Executive Summary
Given Imaging's first-quarter sales of M2A capsule endoscopy systems were ahead of expectations, leading to a 26.6% jump in the firm's stock price in April to $13.85